Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine - PubMed (original) (raw)
Jian-San Zhang, Nan Su, Jian-Guo Xu, Nan Wang, Jiang-Ting Chen, Xin Chen, Yu-Xuan Liu, Hong Gao, Yu-Ping Jia, Yan Liu, Rui-Hua Sun, Xu Wang, Dong-Zheng Yu, Rong Hai, Qiang Gao, Ye Ning, Hong-Xia Wang, Ma-Chao Li, Biao Kan, Guan-Mu Dong, Qi An, Ying-Qun Wang, Jun Han, Chuan Qin, Wei-Dong Yin, Xiao-Ping Dongs
Affiliations
- PMID: 18018769
Clinical Trial
Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine
Jiang-Tao Lin et al. Antivir Ther. 2007.
Abstract
Background: Emergence of severe acute respiratory syndrome (SARS) from the winter of 2002 to the spring of 2003 has caused a serious threat to public health.
Methods: To evaluate the safety and immunogenicity of the inactivated SARS coronavirus (SARS-CoV) vaccine, 36 subjects received two doses of 16 SARS-CoV units (SU) or 32 SU inactivated SARS-CoV vaccine, or placebo control.
Results: On day 42, the seroconversion reached 100% for both vaccine groups. On day 56, 100% of participants in the group receiving 16 SU and 91.1% in the group receiving 32 SU had seroconverted. The geometric mean titre of neutralizing antibody peaked 2 weeks after the second vaccination, but decreased 4 weeks later.
Conclusion: The inactivated vaccine was safe and well tolerated and can elicit SARS-CoV-specific neutralizing antibodies.
Similar articles
- Immunogenicity of SARS inactivated vaccine in BALB/c mice.
Xiong S, Wang YF, Zhang MY, Liu XJ, Zhang CH, Liu SS, Qian CW, Li JX, Lu JH, Wan ZY, Zheng HY, Yan XG, Meng MJ, Fan JL. Xiong S, et al. Immunol Lett. 2004 Sep;95(2):139-43. doi: 10.1016/j.imlet.2004.06.014. Immunol Lett. 2004. PMID: 15388253 Free PMC article. - A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
Spruth M, Kistner O, Savidis-Dacho H, Hitter E, Crowe B, Gerencer M, Brühl P, Grillberger L, Reiter M, Tauer C, Mundt W, Barrett PN. Spruth M, et al. Vaccine. 2006 Jan 30;24(5):652-61. doi: 10.1016/j.vaccine.2005.08.055. Epub 2005 Aug 26. Vaccine. 2006. PMID: 16214268 Free PMC article. - Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain.
Zhang CH, Guo ZM, Zheng HY, Lu JH, Wang YF, Yan XG, Zhao Y, DU XW, Zhang X, Fang L, Ling WH, Qi SY, Yu XB, Zhong NS. Zhang CH, et al. Chin Med J (Engl). 2004 Nov;117(11):1625-9. Chin Med J (Engl). 2004. PMID: 15569476 - Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D. Cavanagh D. Avian Pathol. 2003 Dec;32(6):567-82. doi: 10.1080/03079450310001621198. Avian Pathol. 2003. PMID: 14676007 Free PMC article. Review. - SARS Immunity and Vaccination.
Zhu M. Zhu M. Cell Mol Immunol. 2004 Jun;1(3):193-8. Cell Mol Immunol. 2004. PMID: 16219167 Review.
Cited by
- A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model.
Zhang Y, Zhang J, Li D, Mao Q, Li X, Liang Z, He Q. Zhang Y, et al. Viruses. 2024 Mar 21;16(3):484. doi: 10.3390/v16030484. Viruses. 2024. PMID: 38543849 Free PMC article. - Could SARS-CoV-1 Vaccines in the Pipeline Have Contributed to Fighting the COVID-19 Pandemic? Lessons for the Next Coronavirus Plague.
López D, García-Peydró M. López D, et al. Biomedicines. 2023 Dec 27;12(1):62. doi: 10.3390/biomedicines12010062. Biomedicines. 2023. PMID: 38255169 Free PMC article. - Immunoinformatics lessons on the current COVID-19 pandemic and future coronavirus zoonoses.
López D, García-Peydró M. López D, et al. Front Immunol. 2023 Dec 12;14:1118267. doi: 10.3389/fimmu.2023.1118267. eCollection 2023. Front Immunol. 2023. PMID: 38149247 Free PMC article. No abstract available. - HIV infection and the implication for COVID-19 vaccination.
Oyelade T, Raya RP, Latief K. Oyelade T, et al. Public Health Chall. 2022 Sep;1(3):e14. doi: 10.1002/puh2.14. Epub 2022 Jul 29. Public Health Chall. 2022. PMID: 37521727 Free PMC article. Review. - Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study.
Anderson GP, Irving LB, Jarnicki A, Kedzierska K, Koutsakos M, Kent S, Hurt AC, Wheatley AK, Nguyen THO, Snape N, Upham JW. Anderson GP, et al. ERJ Open Res. 2023 Mar 6;9(2):00641-2021. doi: 10.1183/23120541.00641-2021. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36891079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous